Evangelos L.
- Country
- Greece
- Department
- A' Propedeutic Department of Medicine- Diabetes Center
Research Overview
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
Data & Insights
Has run more than one trial at 666 of 1289 partner sites.
Specializations
Cardiovascular Disease Prevention
This investigator specializes in the prevention of atherosclerotic cardiovascular disease (ASCVD), with particular focus on high-risk primary prevention strategies. Their research encompasses innovative approaches to reduce cardiovascular events in patients with elevated risk factors.
- Primary Prevention Strategies
- Cardiovascular Risk Management
- Lipid-Lowering Therapies
The investigator's work is centered on evaluating novel therapeutic interventions for preventing major adverse cardiovascular events in at-risk populations.
Advanced Cardiology Research
Their expertise extends to treating patients with established vascular disease, focusing on preventing cardiovascular mortality, myocardial infarctions, and ischemic strokes. The investigator studies comprehensive approaches to managing cardiovascular risk in patients with confirmed atherosclerotic disease.
- Vascular Disease Management
- Secondary Prevention
- Cardiovascular Outcomes
The research focuses on developing effective therapeutic strategies for patients with established cardiovascular conditions.
Cardiac Rhythm Management
The investigator has significant expertise in managing atrial fibrillation and its complications, particularly focusing on stroke prevention. Their research includes evaluation of anticoagulation strategies and systematic approaches to preventing embolic events in patients with cardiac arrhythmias.
- Stroke Prevention
- Anticoagulation Therapy
- Systemic Embolism Management
Their work emphasizes the development of safer and more effective treatments for preventing stroke in atrial fibrillation patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.